T1	p 325 370	of 95 patients with atherosclerotic disease .
T2	p 1985 2001	patients who are
T3	i 58 70	lipid esters
T4	i 78 140	lipid-lowering treatment with diet , clofibrate and niceritrol
T5	i 187 197	clofibrate
T6	i 220 221	.
T7	i 263 275	lipid esters
T8	i 300 314	lipid-lowering
T9	i 419 423	diet
T10	i 478 533	clofibrate or niceritrol , a nicotinic acid ester , was
T11	i 642 679	with diet , clofibrate and niceritrol
T12	i 772 784	lipid esters
T13	i 877 878	.
T14	i 928 979	saturated and monounsaturated fatty acids secreased
T15	i 988 1015	polyunsaturated fatty acids
T16	i 1059 1100	pulyunsaturated and saturated fatty acids
T17	i 1134 1140	esters
T18	i 1145 1158	triglycerides
T19	i 1268 1278	clofibrate
T20	i 1285 1295	niceritrol
T21	i 1360 1370	Clofibrate
T22	i 1418 1439	monounsaturated fatty
T23	i 1498 1520	esters , triglycerides
T24	i 1525 1538	phospholipids
T25	i 1594 1607	of linoleic (
T26	i 1617 1621	acid
T27	i 1646 1652	esters
T28	i 1657 1670	triglycerides
T29	i 1732 1744	lipid esters
T30	i 1852 1867	saturated fatty
T31	i 1905 1915	clofibrate
T32	i 1961 1981	clofibrate treatment
T33	i 2007 2046	diet enriched with polyunsaturated fats
T34	i 2096 2126	to monounsaturated fatty acids
T35	i 2147 2153	esters
T36	i 2222 2249	and saturated fatty acids .
T37	i 2283 2293	clofibrate
T38	i 2347 2366	polyunsaturated fat
T39	o 21 43	fatty acid composition
T40	o 51 70	plasma lipid esters
T41	o 126 142	and niceritrol .
T42	o 160 183	proportion of linoleate
T43	o 226 248	fatty acid composition
T44	o 256 262	plasma
T45	o 492 502	niceritrol
T46	o 665 679	and niceritrol
T47	o 706 730	serum lipid reductions .
T48	o 735 757	fatty acid composition
T49	o 765 784	plasma lipid esters
T50	o 849 878	degree of dietary adherence .
T51	o 970 979	secreased
T52	o 1045 1050	ratio
T53	o 1101 1114	( P/S ratio )
T54	o 1134 1140	esters
T55	o 1145 1160	triglycerides .
T56	o 1172 1179	changes
T57	o 1285 1295	niceritrol
T58	o 1335 1357	fatty acid composition
T59	o 1360 1380	Clofibrate treatment
T60	o 1498 1538	esters , triglycerides and phospholipids
T61	o 1646 1652	esters
T62	o 1657 1672	triglycerides .
T63	o 1689 1696	1 ratio
T64	o 1770 1779	P/S ratio
T65	o 1868 1873	acids
T66	o 2134 2146	plasma lipid
T67	o 2254 2272	fatty acid changes